Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

AUDIO from Medialink and Duramed Pharmaceuticals: Option to Alleviate Menopausal Symptoms

Wed. September 03, 2008; Posted: 06:45 PM
Stocks RSS
NEW YORK, Sept 03, 2008 /PRNewswire via COMTEX/ -- DRMD | Quote | Chart | News | PowerRating -- Approximately 5,700 women enter menopause every day. Many women are seeking relief for the symptoms associated with menopause. Unfortunately, not all available treatment options are FDA-approved for their safety and efficacy. Here's more information on an available option that is well tested and FDA-approved.

Listen to this report from Duramed Pharmaceuticals at: http://media.medialink.com/WebNR.aspx?story=35514

Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://www.mediaseed.tv.

09NY08-0085

SOURCE Medialink and Duramed Pharmaceuticals

http://media.medialink.com/WebNR.aspx?story=35514

For full details for DRMD click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [DRMD]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.